Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Efficacy and Impact of a Personalized Smoking Cessation Intervention Among Type 2 Diabetic Smokers in a Randomized Controlled Trial

NCT03426423 is registered in ClinicalTrials.gov with Carole Clair as lead sponsor.

NCT NCT03426423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03426423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Efficacy and Impact of a Personalized Smoking Cessation Intervention Among Type 2 Diabetic Smokers in a Randomized Controlled Trial
Lead sponsor
Carole Clair
Phase
Not applicable
Overall status
Terminated
Start date
March 1, 2018
Completion date
March 10, 2021
Enrollment
48 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type 2, smoking cessation